168 related articles for article (PubMed ID: 30922255)
1. Establishing of mouse oral carcinoma cell lines derived from transgenic mice and their use as syngeneic tumorigenesis models.
Chen YF; Liu CJ; Lin LH; Chou CH; Yeh LY; Lin SC; Chang KW
BMC Cancer; 2019 Mar; 19(1):281. PubMed ID: 30922255
[TBL] [Abstract][Full Text] [Related]
2. Establishment of syngeneic murine model for oral cancer therapy.
Chen YF; Chang KW; Yang IT; Tu HF; Lin SC
Oral Oncol; 2019 Aug; 95():194-201. PubMed ID: 31345390
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
[TBL] [Abstract][Full Text] [Related]
4. K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression.
Tseng SH; Yang CC; Yu EH; Chang C; Lee YS; Liu CJ; Chang KW; Lin SC
Int J Cancer; 2015 Mar; 136(6):1263-75. PubMed ID: 25082302
[TBL] [Abstract][Full Text] [Related]
5. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):301-13. PubMed ID: 14734483
[TBL] [Abstract][Full Text] [Related]
6. Isolation of differentiated squamous and undifferentiated spindle carcinoma cell lines with differing metastatic potential from a 4-nitroquinoline N-Oxide-induced tongue carcinoma in a F344 rat.
Takeuchi S; Nakanishi H; Yoshida K; Yamamoto S; Tonoki H; Tsukamoto T; Fukushima S; Moriuchi T; Kurita K; Tatematsu M
Jpn J Cancer Res; 2000 Dec; 91(12):1211-21. PubMed ID: 11123419
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a
Chang KW; Lin CE; Tu HF; Chung HY; Chen YF; Lin SC
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302499
[TBL] [Abstract][Full Text] [Related]
8. A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.
Tan MT; Wu JG; Callejas-Valera JL; Schwarz RA; Gillenwater AM; Richards-Kortum RR; Vigneswaran N
Int J Exp Pathol; 2020 Feb; 101(1-2):45-54. PubMed ID: 32436348
[TBL] [Abstract][Full Text] [Related]
9. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
[TBL] [Abstract][Full Text] [Related]
10. p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene.
Ide F; Kitada M; Sakashita H; Kusama K; Tanaka K; Ishikawa T
Am J Pathol; 2003 Nov; 163(5):1729-33. PubMed ID: 14578172
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
14. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer.
Lin J; Lin Y; Fan L; Kuang W; Zheng L; Wu J; Shang P; Wang Q; Tan J
Biochem Biophys Res Commun; 2016 Apr; 473(2):382-7. PubMed ID: 26946357
[TBL] [Abstract][Full Text] [Related]
15. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
[TBL] [Abstract][Full Text] [Related]
16. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.
Sano D; Xie TX; Ow TJ; Zhao M; Pickering CR; Zhou G; Sandulache VC; Wheeler DA; Gibbs RA; Caulin C; Myers JN
Clin Cancer Res; 2011 Nov; 17(21):6658-70. PubMed ID: 21903770
[TBL] [Abstract][Full Text] [Related]
17. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
19. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
20. Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice.
Feith DJ; Pegg AE; Fong LY
Carcinogenesis; 2013 Mar; 34(3):570-6. PubMed ID: 23222816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]